Antibiotic study for bile problems after liver transplant
Part of Digestive system clinical trials.
This study looks at how an antibiotic moves through the body of liver transplant patients who have bile complications like leaks or abscesses. It aims to ensure the antibiotic reaches the bile in the right amount to fight infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older)
- You have received a liver transplant and are being treated at the University Hospital of Grenoble (CHUGA)
- You have bile leaks (biliomas), bile in the abdomen, or liver abscesses that showed up on ultrasound, CT scan, or MRI
- You are having a bile duct exam (endoscopy) or drainage procedure within 96 hours to 6 weeks after starting antibiotics
- You have health insurance (social security) and are not under guardianship or in prison
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what germs cause infections in people who have had a liver transplant. It aims to help doctors better prevent and treat infections after transplant.
This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.
This study tests whether giving antibiotics before liver or bile duct surgery can prevent wound infections in areas where bacteria are resistant to many antibiotics. You would receive antibiotics as a preventive measure and be monitored for any surgical site infections.
This study compares two ways of giving preventive antibiotics to liver transplant patients who carry resistant bacteria. The goal is to see if targeted antibiotics work better than standard ones at preventing infections without causing more side effects.
This early-phase study tests whether the antibiotic vancomycin can help children with primary sclerosing cholangitis or biliary atresia, and related gut/bile duct problems. It may work by changing gut bacteria, but you would need to avoid certain medicines beforehand.
This trial compares a treatment using a stool transplant (from a healthy donor in capsules) to standard care for people who have had at least two bile duct infections in the past year. It aims to see if the stool transplant can prevent future infections.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.